This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Fetal Death
and you are
between 18 and 64
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The primary aim of this trial is to compare the efficacy of mifepristone-misoprostol versus misoprostol alone for treatment of intrauterine fetal demise between 14 and 28 weeks LMP.

Provided treatments

  • Drug: Mifepristone
  • Drug: Placebo
  • Drug: Misoprostol 200mcg

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02633761. The sponsor of the trial is Gynuity Health Projects and it is looking for 200 volunteers for the current phase.
Official trial title:
Mifepristone and Misoprostol Versus Misoprostol Alone for Treatment of Fetal Death at 14-28 Weeks of Pregnancy: A Randomized, Placebo-controlled Double-blinded Trial